| Pendulous Breast Radiotherapy in Prone Position | Ali Rıza ÜÇER, Gülçin ERTAŞ, Kenan ÖZBAĞI, Hayati ABANUZ, Muzaffer Bedri ALTUNDAĞ, Tamer ÇALIKOĞLU, Yasemin GÜZLE ADAŞ, Serap UYAR, Atilla DEMİRKASIMOĞLU, Sena DURMUŞ DÜZGÜN, Erdal DEMİR | 189–193 |
| Evaluation of Prognostic Factors Affecting Disease-Free Survival and Overall Survival in Patients with Operated Gastric Cancer Treated with Adjuvant Treatment | Cengiz KARAÇİN, Umut DEMİRCİ, Ömür Berna ÖKSÜZOĞLU, İrem BİLGETEKİN, Fatma BUĞDAYCI BAŞAL | 194–203 |
| Evaluation of oncological and functional outcomes in robot-assisted partial nephrectomy for renal tumors with intermediate and high risk RENAL nephrometry scores | Murat SAVAŞ, Mutlu ATEŞ, Çağatay ÖZSOY, Kaan KARAMIK, Ekrem İSLAMOĞLU, Mehmet Salih BAĞ | 204–209 |
| Concordance Between İntraoperative Frozen Section And Final Pathologyİn Adnexal Masses Using The Kappa Test | Çetin AYDIN, İrfan ÖCAL, Hakan ÇÖKMEZ, Simge TEZEL YOZGAT | 210–218 |
| The long-term oncological results of patients under 55-year-old who underwent radical retropubic prostatectomy for localized prostate cancer | Cüneyt ÖZDEN, Süleyman BULUT, Binhan Kağan AKTAŞ, Samet ŞENEL, Yalçın KIZILKAN | 219–224 |
| The Results of Single Bone Forearm Procedure for Malignant ProximalRadius Tumors | Abdullah MERTER, Yusuf YILDIZ, Kerem BAŞARIR, Mustafa Onur KARACA | 225–230 |
| Clinical And Pathological Characteristics Of pT0 Patients After Robot Assisted Laparoscopic Radical Prostatectomy | Bahri GÖK, Erdem KOÇ | 231–236 |
| Advanced age in non-metastatic prostate cancer: does it matter on the oncological outcomes? | Özer Ural ÇAKICI, Serkan ALTINOVA, Abdullah Erdem CANDA, Nurullah HAMİDİ | 237–244 |
| Quality of Life in Chronic Myeloid Leukemia Patients in the Era of GenericImatinib | Eren GÜNDÜZ, Nur OĞUZ DAVUTOĞLU, Beyhan DURAK ARAS, Abide Günnur BALCI GÜÇLÜ | 245–249 |
| The Prognostic Impact of the Neutrophil-Lymphocyte Ratio in Small-CellLung Cancer | Mevlüde İNANÇ, Cengiz KARAÇİN, Mustafa ALTINBAŞ | 250–255 |
| Accompanying prostate pathologies in patients undergoing radical cystoprostatectomy due to bladder cancer |